In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae

Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii

(2021) Jiaqi Cheng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii

(2020) Brian Luna et al.   Nature Microbiology

In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms

(2020) Vincent Trebosc et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter Infections

(2020) M C Phillips et al.   Open Forum Infectious Diseases

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria

(2019) Brian M Luna et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Natural history of Acinetobacter baumannii infection in mice

(2019) Brian M. Luna et al.   PLoS One

Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens

(2019) Nicholas Dillon et al.   EBioMedicine

Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis

(2017) Travis B Nielsen et al.   JOURNAL OF INFECTIOUS DISEASES

Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing

(2017) Selvi C. Ersoy et al.   EBioMedicine

The Accidental Orthodoxy of Drs. Mueller and Hinton

(2017) Victor Nizet   EBioMedicine

Host Fate is Rapidly Determined by Innate Effector-Microbial Interactions During Acinetobacter baumannii Bacteremia

(2014) K. W. Bruhn et al.   JOURNAL OF INFECTIOUS DISEASES

The value of single-pathogen antibacterial agents

(2013) Brad Spellberg et al.   NATURE REVIEWS DRUG DISCOVERY

Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

(2010) M. E. Pachon-Ibanez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances

(2008) Irith Wiegand et al.   Nature Protocols